Literature DB >> 25913622

Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.

Xuren Sun1, Zhe Sun2, Zhi Zhu2, Chenyan Li3, Junyan Zhang2, Huimian Xu2, Mingjun Sun4,5.   

Abstract

Smad interacting protein 1 (SIP1) plays an important role in the epithelial-mesenchymal transition (EMT) process by downregulating E-cadherin. Lactate dehydrogenase A (LDHA) is a crucial enzyme that plays an important role in the final step of the Warburg effect by converting pyruvate to lactate irreversibly. EMT and Warburg effect are the hallmarks of advanced gastric cancer progression. Recently, EMT has been thought to be implicated in cancer metabolism. In this study, we want to find whether there was a correlation between the expressions of SIP1 and LDHA in gastric cancer and whether expression of SIP1 alone or in combination with LDHA is associated with the progression of gastric cancer. In the present study, we examined SIP1 and LDHA expression by immunohistochemistry analysis on tissue microarray (TMA) containing tumor tissues and matched non-neoplastic mucosa (NNM). Prognostic value and correlation with other clinicopathologic factors were evaluated. In this study, we investigated the expression of SIP1 and LDHA in 261 cancer tissues and their matched NNM using tissue microarray. The immunohistochemistry analysis showed that the expression of SIP1 and LDHA was significantly higher in cancer tissues than in NNM (P = 0.002 P = 0.000, respectively). The expression of SIP1was significantly associated with age, Lauren grade, and histologic differentiation (P < 0.05). The expression of SIP1 was strongly correlated with LDHA expression in gastric cancer (P = 0.000, R = 0.589). The combined expression of SIP1 and LDHA was significantly associated with age, Lauren grade, and histologic differentiation (P < 0.05). Survival analysis demonstrated that the expression of SIP1 or LDHA was associated with significantly shorter overall survival (OS) (P = 0.003, P = 0.000, respectively) and disease-free survival (DFS) (P = 0.003, P = 0.000, respectively). The combined expression of SIP1 and LDHA was associated with less survival time in gastric cancer patients (P = 0.000). The multivariate analysis showed that the expressions of SIP1 and LDHA in gastric cancer (GC) were independent prognostic factors for OS (hazard ratio = 1.465, 95 %CI 1.128-1.901, P = 0.004, hazard ratio = 1.514, 95 %CI 1.091-2.101 P = 0.013, respectively) and DFS (hazard ratio = 1.461, 95 %CI 1.130-1.890, P = 0.004, hazard ratio = 1.550 95 %CL1.119-2.147 P = 0.008, respectively). Our study indicated that expressions of SIP1 and LDHA are independent prognostic factors in gastric cancer patients and may be predictive of poor outcomes.

Entities:  

Keywords:  Gastric carcinoma; LDHA; Prognosis; SIP1; Tissue microarray

Mesh:

Substances:

Year:  2015        PMID: 25913622     DOI: 10.1007/s13277-015-3470-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

Review 3.  Tumor metastasis: a new twist on epithelial-mesenchymal transitions.

Authors:  Ann E Vernon; Carole LaBonne
Journal:  Curr Biol       Date:  2004-09-07       Impact factor: 10.834

4.  [Forensic application of investigator Argus X-12 kit in Han population from East China].

Authors:  Su-Hua Zhang; Ru-Xin Zhu; Li Li; Cheng-Tao Li
Journal:  Fa Yi Xue Za Zhi       Date:  2011-10

5.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

6.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

Authors:  H Shim; C Dolde; B C Lewis; C S Wu; G Dang; R A Jungmann; R Dalla-Favera; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 7.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.

Authors:  Feng Yao; Tiejun Zhao; Chenxi Zhong; Ji Zhu; Heng Zhao
Journal:  Tumour Biol       Date:  2012-09-08

9.  Poor survival for US Pacific Islander cancer patients: evidence from the Surveillance, Epidemiology, and End Results database: 1991 to 2004.

Authors:  William B Goggins; Grace K C Wong
Journal:  J Clin Oncol       Date:  2007-12-20       Impact factor: 44.544

10.  Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells.

Authors:  Yuting Sun; Anneleen Daemen; Georgia Hatzivassiliou; David Arnott; Catherine Wilson; Guanglei Zhuang; Min Gao; Peter Liu; Aaron Boudreau; Leisa Johnson; Jeff Settleman
Journal:  Cancer Metab       Date:  2014-11-03
View more
  7 in total

Review 1.  Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis.

Authors:  Chandra Prakash Prasad; Ajay Gogia; Atul Batra
Journal:  Clin Transl Oncol       Date:  2022-06-25       Impact factor: 3.340

2.  Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome.

Authors:  Goran Hamid Mohammad; S W M Olde Damink; Massimo Malago; Dipok Kumar Dhar; Stephen P Pereira
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

3.  Prognostic significance of the epithelial-mesenchymal transition factor zinc finger E-box-binding homeobox 2 in esophageal squamous cell carcinoma.

Authors:  Xiaodong Huo; Bin Huo; Huixing Wang; Hongdian Zhang; Zhao Ma; Mingjian Yang; Haitao Wang; Zhentao Yu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

4.  Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.

Authors:  Huihui Chen; Wei Lu; Chongjie Huang; Kefeng Ding; Dajing Xia; Yihua Wu; Mao Cai
Journal:  Oncotarget       Date:  2017-05-09

5.  MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.

Authors:  Daozhang Yuan; Shunsheng Zheng; Liyan Wang; Jing Li; Jianan Yang; Bin Wang; Xiong Chen; Xiaobo Zhang
Journal:  Oncotarget       Date:  2017-06-28

6.  Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.

Authors:  Annamaria Ruzzo; Francesco Graziano; Irene Bagaloni; Maria Di Bartolomeo; Michele Prisciandaro; Giuseppe Aprile; Elena Ongaro; Bruno Vincenzi; Giuseppe Perrone; Daniele Santini; Lorenzo Fornaro; Caterina Vivaldi; Gianluca Tomasello; Fotios Loupakis; Sara Lonardi; Matteo Fassan; Michele Valmasoni; Donatella Sarti; Paola Lorenzini; Vincenzo Catalano; Renato Bisonni; Michela Del Prete; Guido Collina; Mauro Magnani
Journal:  Gastric Cancer       Date:  2020-05-05       Impact factor: 7.370

7.  Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase.

Authors:  Xi Wang; Chunbin Wang; Haijun Zhang
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.